The missing 'D' in U.S. Foreign relations law von Moore, David H

Volltext

A phase II trial of radiation therapy and weekly cisplatin chemotherapy for the treatment of locally-advanced squamous cell carcinoma of the vulva: A gynecologic oncology group stu... von Moore, David H, Ali, Shamshad, Koh, Wui-Jin, Michael, Helen, Barnes, Mack N, McCourt, Carolyn K, Homesley, Howard D, Walker, Joan L

Volltext

Phase III Study of Cisplatin With or Without Paclitaxel in Stage IVB, Recurrent, or Persistent Squamous Cell Carcinoma of the Cervix: A Gynecologic Oncology Group Study von MOORE, David H, BLESSING, John A, ROCERETO, Thomas F, MCQUELLON, Richard P, THALER, Howard T, CELLA, David, BENDA, Jo, MILLER, David S, OLT, George, KING, Stephanie, BOGGESS, John F

Volltext

Is age a prognostic biomarker for survival among women with locally advanced cervical cancer treated with chemoradiation? An NRG Oncology/Gynecologic Oncology Group ancillary data... von Moore, Kathleen N., MD, Java, James J., PhD, Slaughter, Katrina N., MD, Rose, Peter G., MD, Lanciano, Rachelle, MD, DiSilvestro, Paul A., MD, Thigpen, J. Tate, MD, Lee, Yi-Chun, MD, Tewari, Krishnansu S., MD, Chino, Junzo, MD, Seward, Shelly M., MD, Miller, David S., MD, Salani, Ritu, MD, Moore, David H., MD, Stehman, Frederick B., MD

Volltext

Circulating Tumor Cells In Advanced Cervical Cancer: NRG Oncology-Gynecologic Oncology Group Study 240 (NCT 00803062) von Tewari, Krishnansu S, Sill, Michael W, Monk, Bradley J, Penson, Richard T, Moore, David H, Lankes, Heather A, Ramondetta, Lois M, Landrum, Lisa M, Randall, Leslie M, Oaknin, Ana, Leitao, Mario M, Eisenhauer, Eric L, DiSilvestro, Paul, Van Le, Linda, Pearl, Michael L, Burke, James J, Salani, Ritu, Richardson, Debra L, Michael, Helen E, Kindelberger, David W, Birrer, Michael J

Volltext

Prognostic factors for response to cisplatin-based chemotherapy in advanced cervical carcinoma: A Gynecologic Oncology Group Study von Moore, David H, Tian, Chunqiao, Monk, Bradley J, Long, Harry J, Omura, George A, Bloss, Jeffrey D

Volltext

CONSTITUTIONAL COMMITMENT TO INTERNATIONAL LAW COMPLIANCE? von Moore, David H.

Volltext

Secondary Surgical Cytoreduction for Advanced Ovarian Carcinoma von Rose, Peter G, Nerenstone, Stacy, Brady, Mark F, Clarke-Pearson, Daniel, Olt, George, Rubin, Stephen C, Moore, David H, Small, James M

Volltext

Randomized Comparison of Weekly Cisplatin or Protracted Venous Infusion of Fluorouracil in Combination With Pelvic Radiation in Advanced Cervix Cancer: A Gynecologic Oncology Group... von LANCIANO, Rachelle, CALKINS, Alison, BUNDY, Brian N, PARHAM, Groesbeck, LUCCI, Joseph A, MOORE, David H, MONK, Bradley J, O'CONNOR, Dennis M

Volltext

Reflections on vulvar tumors, lymphatic drainage, and sentinel lymph node biopsy von Moore, David H., MD

Volltext

Quality of life and survival in advanced cervical cancer: A Gynecologic Oncology Group study von Chase, Dana M, Huang, Helen Q, Wenzel, Lari, Cella, David, McQuellon, Richard, Long, Harry J, Moore, David H, Monk, Bradley J

Volltext

Bevacizumab for advanced cervical cancer: final overall survival and adverse event analysis of a randomised, controlled, open-label, phase 3 trial (Gynecologic Oncology Group 240) von Tewari, Krishnansu S, Sill, Michael W, Penson, Richard T, Huang, Helen, Ramondetta, Lois M, Landrum, Lisa M, Oaknin, Ana, Reid, Thomas J, Leitao, Mario M, Michael, Helen E, DiSaia, Philip J, Copeland, Larry J, Creasman, William T, Stehman, Frederick B, Brady, Mark F, Burger, Robert A, Thigpen, J Tate, Birrer, Michael J, Waggoner, Steven E, Moore, David H, Look, Katherine Y, Koh, Wui-Jin, Monk, Bradley J

Volltext

Revitalizing tribal sovereignty in treatymaking von Moore, David H, Steele, Michalyn

Volltext

Cervical cancer von MOORE, David H

Volltext

A phase II study of docetaxel in paclitaxel-resistant ovarian and peritoneal carcinoma: a gynecologic oncology group study von Rose, Peter G, Blessing, John A, Ball, Harrison G, Hoffman, James, Warshal, David, DeGeest, Koen, Moore, David H

Volltext

Quality of life (QOL) outcomes from a randomized trial of cisplatin versus cisplatin plus paclitaxel in advanced cervical cancer: A Gynecologic Oncology Group study von McQuellon, Richard P., Thaler, Howard T., Cella, David, Moore, David H.

Volltext

Preoperative chemoradiation for advanced vulvar cancer: a phase II study of the Gynecologic Oncology Group von Moore, David H, Thomas, Gillian M, Montana, Gustavo S, Saxer, Angelika, Gallup, Donald G, Olt, George

Volltext

ACR Appropriateness Criteria® Pretreatment Planning of Invasive Cancer of the Cervix von Siegel, Cary Lynn, MD, Andreotti, Rochelle F., MD, Cardenes, Higinia Rosa, MD, PhD, Brown, Douglas L., MD, Gaffney, David K., MD, PhD, Horowitz, Neil S., MD, Javitt, Marcia C., MD, Lee, Susanna I., MD, PhD, Mitchell, Donald G., MD, Moore, David H., MD, Rao, Gautam G., MD, Royal, Henry D., MD, Small, William, MD, Varia, Mahesh A., MD, Yashar, Catheryn M., MD

Volltext

Limited Access Trial Using Amifostine for Protection Against Cisplatin- and Three-Hour Paclitaxel–Induced Neurotoxicity: A Phase II Study of the Gynecologic Oncology Group von MOORE, David H, DONNELLY, James, MCGUIRE, William P, ALMADRONES, Lois, CELLA, David F, HERZOG, Thomas J, WAGGONER, Steven E

Volltext

Final survival analysis of topotecan and paclitaxel for first-line treatment of advanced cervical cancer: An NRG oncology randomized study von Tewari, Krishnansu S., Sill, Michael W., Birrer, Michael J., Penson, Richard T., Huang, Helen, Moore, David H., Ramondetta, Lois M., Landrum, Lisa M., Oaknin, Ana, Reid, Thomas J., Leitao, Mario M., Michael, Helen E., Monk, Bradley J.

Volltext